ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Natural anthraquinone compound emodin as a novel inhibitor of aurora A kinase: A pilot study

Wu, Fen-Lan; Chu, Pei-Yi; Chen, Guan-Yu; Wang, Ke; Hsu, Wei-Yu; Ahmed, Azaj; Ma, Wen-Lung; Cheng, Wei-Chung; Wu, Yang-Chang*; Yang, Juan-Cheng*中国医科大学
Chemical Biology and Drug Design2022-1DOI: 10.1111/cbdd.13938
7被引1阅读
引用收藏
分享

摘要

Aurora kinase A (AURKA) carries out an essential role in proliferation and involves in cisplatin resistance in various cancer cells. Overexpression of AURKA is associated with the poor prognosis of cancer patients. Thus, AURKA has been considered as a target for cancer therapy. Developing AURKA inhibitors became an important issue in cancer therapy. A natural compound emodin mainly extracted from rhubarbs possesses anti-cancer properties. However, the effect of emodin on AURKA has never been investigated. In the present study, molecular docking analysis indicated that emodin interacts with AURKA protein active site. We also found nine emodin analogues from Key Organic database by using ChemBioFinder software. Among that, one analogue 8L-902 showed a similar anti-cancer effect as emodin. The bindings of emodin and 8L-902 on AURKA protein were confirmed by cellular thermal shift assay. Furthermore, emodin inhibited the AURKA kinase activity in vitro and enhanced the cisplatin-DNA adduct level in a resistant ovarian cancer cell line. It seems that emodin may have the potential to inhibit cancer cell growth and enhance cisplatin therapy in cancer with resistance. Collectively, our finding reveals a novel AURKA inhibitor, emodin, which may be vulnerable to ovarian cancer therapy in the future.

学科与关键词

关键词
analogueAurora kinase Aemodininhibitorovarian cancer
相关
加载中…
  • Novel Aurora A Kinase Inhibitor Fangchinoline Enhances Cisplatin-DNA Adducts and Cisplatin Therapeutic Efficacy in OVCAR-3 Ovarian Cancer Cells-Derived Xenograft Model
    Winardi, Daniel; Chu, Pei-Yi; Chen, Guan-Yu; Wang, Ke; Hsu, Wei-Yu; Hsieh, Ching-Liang; Chen, Yung-Hsiang; Wu, Yang-Chang*; Yang, Juan-Cheng*INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23(3): 1868.被引 5
  • Anlotinib induces apoptosis and second growth/mitosis phase block in cisplatin-resistant ovarian cancer cells via the aurora kinase A/p53 pathway
    Wang, Hongli*; Wang, YuHuman and Experimental Toxicology, 2023, 42: 09603271231185774.被引 1
  • SARI 56497, an Exquisitely Selective Inhibitor of Aurora Kinases
    Carry, Jean-Christophe*; Clerc, Francois; Minoux, Herve; Schio, Laurent; Mauger, Jacques; Nair, Anil; Parmantier, Eric; Le Moigne, Ronan; Delorme, Cecile; Nicolas, Jean-Paul; Krick, Alain; Abecassis, Pierre-Yves; Crocq-Stuerga, Veronique; Pouzieux, Stephanie; Delarbre, Laure; Maignan, Sebastien; Bertrand, Thomas; Bjergarde, Kirsten; Ma, Nina; Lachaud, Sylvette; Guizani, Houlfa; Lebel, Remi; Doerflinger, Gilles; Monget, Sylvie; Perron, Sebastien; Gasse, FrancisJournal of Medicinal Chemistry, 2015, 58(1): 362-375.被引 27
查看全部 →

发表信息

论文状态
公开发表
期刊
Chemical Biology and Drug Design
发表日期
2022-01
卷期
第 99 卷, 第 1 期
页码
126-135
DOI
10.1111/cbdd.13938
语言
ENGLISH
成果收录
SCIE
资助标注
China Medical University [CMU109-MF-15]; Ministry of Science and Technology [MOST 107-2320-B-039-017-MY3, MOST 109-2327-B-039-002, MOST 108-2320-B-039-062]

作者

  • W

    Wu, Fen-Lan (第一作者)

    nanjing med univ

  • C

    Chu, Pei-Yi

    china med univ hosp

查看全部 10 位作者收起作者
  • C

    Chen, Guan-Yu

    china med univ hosp

  • W

    Wang, Ke

    china med univ hosp

  • H

    Hsu, Wei-Yu

    china med univ hosp

  • A

    Ahmed, Azaj

    china med univ hosp

  • M

    Ma, Wen-Lung

    china med univ hosp

  • C

    Cheng, Wei-Chung

    china med univ · china med univ hosp

  • W

    Wu, Yang-Chang (通讯)

    china med univ · china med univ hosp

  • Y

    Yang, Juan-Cheng (通讯)

    china med univ · china med univ hosp

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417